prof. dr hab. Piotr Popik

prof. dr hab. Piotr Popik

+48 12 6623375
pokój 30
Zakład Badań Nowych Leków

Dokonania naukowe

  • Publikacje

Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence

Autorzy: Popik, P., Krawczyk, M., Kos, T., Nalepa, I., Kowalska, M., Witarski, T., Antkiewicz-Michaluk, L., Vetulani, J.

DOI: 10.1016/j.ejphar.2005.04.009
Date: 2005-01-01

A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice

Autorzy: Kos, T., Popik, P.

DOI: 10.1097/00008877-200505000-00004
Date: 2005-01-01

Neramexane, a novel NMDA receptor antagonist, potentiates the antidepressant-like activity of different antidepressants in the mouse tail suspension test

Autorzy: Piotr Popik

DOI:
Date: 2004-01-01

Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice.

Autorzy: Popik P, Wrobel M, Rygula R, Bisaga A, Bespalov AY

DOI: 10.1097/01.fbp.0000074774.49104.0e
Date: 2003-05-01

Antidepressant-like actions of DOV 21,947: A "triple" reuptake inhibitor

Autorzy: Skolnick, P., Popik, P., Janowsky, A., Beer, B., Lippa, A.S.

DOI: 10.1016/S0014-2999(03)01310-4
Date: 2003-01-01

GPI 5693, a selective GCP II inhibitor, prevents morphine antinociceptive tolerance and potentiates withdrawal in mice

Autorzy: Piotr Popik

DOI:
Date: 2003-01-01

"Broad spectrum" antidepressants: Is more better for the treatment of depression?

Autorzy: Skolnick, P., Popik, P., Janowsky, A., Beer, B., Lippa, A.S.

DOI: 10.1016/j.lfs.2003.06.007
Date: 2003-01-01

Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram

Autorzy: Popik, P., Kozela, E., Krawczyk, M.

DOI: 10.1038/sj.bjp.0705359
Date: 2003-01-01

Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice

Autorzy: Popik, P., Wrobel, M., Rygula, R., Bisaga, A., Bespalov, A.Y.

DOI:
Date: 2003-01-01

Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA.

Autorzy: Popik, P., Kozela, E., Wróbel, M., Wozniak, K.M., Slusher, B.S.

DOI:
Date: 2003-01-01

Zobacz także